title: Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.
authors.affiliation: AstraZeneca R&D Mölndal, S-431 82 Mölndal, Sweden. Nick.Oakes@astrazeneca.com
authors.forename: Nicholas D
authors.initials: ND
authors.lastname: Oakes
authors.forename: Bengt
authors.initials: B
authors.lastname: Ljung
authors.forename: Germán
authors.initials: G
authors.lastname: Camejo
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology* / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism*; D006801:Humans; D020025:Peroxisome Proliferators / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D014157:Transcription Factors / Q000378:metabolism*
chemical_list: D005227:Fatty Acids; D020025:Peroxisome Proliferators; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors